Rasburicase biosimilar (Virchow Group)

Product Name :
Rasburicase biosimilar (Virchow Group)

Search keywords :
Rasburicase

drugId :
null

Target Vo:
Urate oxidase

Target Vo Short Name :
UOX

Moa_Name:
Urate oxidases replacements

First Approval Country :
India

First Approval Date Filter:
2012

Origin Company_Name :
Virchow Group

Active Company_Name :
Virchow Group

Active Indication_Name:
Hyperuricemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD11c Antibody site
Mirvetuximab manufacturer
Beta-Catenin Antibody: Beta-Catenin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Beta-Catenin. It can be used for WB,IHC-P,IF,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts